WHO ICTRP trial
EFFICACY AND SAFETY OF INTENSIVE INSULIN THERAPY WITH INSULIN GLULISINE IN…
PER-119-10 · Registro Peruano de Ensayos Clínicos (REPEC) · Not Recruiting
Key facts
| Trial ID | PER-119-10 |
|---|---|
| Public title | EFFICACY AND SAFETY OF INTENSIVE INSULIN THERAPY WITH INSULIN GLULISINE IN PATIENTS WITH TYPE 2 DIABETES INADEQUATELY CONTROLLED WITH BASAL INSULIN AND ORAL GLUCOSE-LOWERING DRUGS |
| Scientific title | EFFICACY AND SAFETY OF INTENSIVE INSULIN THERAPY WITH INSULIN GLULISINE IN PATIENTS WITH TYPE 2 DIABETES INADEQUATELY CONTROLLED WITH BASAL INSULIN AND ORAL GLUCOSE-LOWERING DRUGS |
| Primary sponsor | sanofi-aventis Recherche & Development, |
| Registry | Registro Peruano de Ensayos Clínicos (REPEC) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | IV |
| Countries | United Arab Emirates;Israel;Lebano;Argeria;Morocco;Brazil;Mexico;Peru;Venezuela;Arabia Saudi |
| Conditions | -E11 Non-insulin-dependent diabetes mellitus Non-insulin-dependent diabetes mellitus;E11 ;Non-insulin-dependent diabetes mellitus |
| Interventions | Group name:Group 1 Type of group;1 N° of participants:100 Intervention(s) description:Treatment Period 1: Insulin glargine + metformin + other OGLDs, if any Treatment period 2: + insulin glulisine if HbA1c ≥7% at week 12 (end of treatment… |
| Registration date | Feb 21, 2011 |
| Target size | 20 |
| Secondary IDs | NCT01203111 |
| Registry page | ins.gob.pe |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: